TY  - JOUR

T1  - Corrigendum to “Immunogenicity and safety of co-administration of a recombinant shingles vaccine with an mRNA COVID-19 or adjuvanted influenza vaccine: A randomised controlled trial” [J Infect 93 (2026) 106784]

JO  - Journal of Infection

UR  - https://doi.org/10.1016/j.jinf.2026.106853

PY  - 2026/10/01

AU  - Harris R

AU  - Thirard R

AU  - Iftikhar H

AU  - Middleditch A

AU  - Chadwick D

AU  - Jackson J

AU  - Moran E

AU  - Perry J

AU  - Payne RO

AU  - Goodman AL

AU  - Cosgrove C et al

ED  - 

DO  - DOI: 10.1016/j.jinf.2026.106853

PB  - Elsevier BV

VL  - 93

IS  - 4

SP  - 106853

EP  - 106853

Y2  - 2026/09/28

ER  -